10 Voters on Panel Backing Pain Pills Had Industry Ties

Article Abstract:

10 of the 32 members of an advisory panel that recently voted in favor of advising the Food and Drug Administration to allow the sale of painkillers Celebrex, Bextra and Vioxx have had previous relationships with the pharmaceutical industry.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

For Merck, Defense of a Drug Crumbles at a Difficult Time

Article Abstract:

Merck and Company has discontinued the arthritis and pain medication Vioxx because of studies linking it to increased heart disease and stroke risk, prompting industry analysts to question why the decision had taken so long.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Pfizer Warns of Risks From Its Painkiller

Article Abstract:

Pfizer has warned that its arthritis medication Bextra, like Merck's Vioxx, may increase the risk of heart attack and stroke.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: